Our Collaborators

We work with leading researchers to investigate the benefits of Mitoquinol Mesylate across health and disease.

A black-and-white photo of a middle-aged man with glasses, short light hair, wearing a suit jacket and dress shirt, standing outdoors in front of a building.

Prof. Mike Murphy

Mitochondrial biology, redox chemistry

Co-inventor of mitoquinol, Prof. Murphy is a global leader in mitochondrial-targeted therapeutics. His foundational work focuses on targeting antioxidants to mitochondria to reduce oxidative stress and improve cellular function.

University: University of Cambridge
A smiling middle-aged man with a shaved head wearing a checkered button-up shirt and a suit jacket, standing outdoors.

Prof. Doug Seals

Vascular ageing, cardiovascular physiology


Leads clinical research investigating mitoquinol to improve endothelial function and reduce arterial stiffness in older adults by targeting mitochondrial ROS.


Trial:Age-related vascular dysfunction (NCT04851288)

University of Colorado Boulder
Black and white portrait of a smiling man with short hair, facial hair, and wearing a collared shirt. 
Assistant Research Professor, University of Colorado.

Dr Matthew Rossman

Endothelial function, vascular ageing
Focuses on the mechanistic effects of mitoquinol on nitric oxide bioavailability and mitochondrial oxidative stress in ageing vasculature.

Trial: Age-related vascular dysfunction (NCT04851288)

A woman with glasses and shoulder-length hair smiling, wearing a white lab coat in a modern indoor setting.
Black and white portrait of a smiling man wearing a white lab coat with his name, Matthew Durand, Ph.D., embroidered on it, in a professional setting. 
Professor, Medicine-Geriatrics. University of Colorado, Boulder.

Prof. Kerrie Moreau

Women’s cardiovascular health, ageing

Researches sex-specific vascular ageing and the role of mitochondrial oxidative stress, with a focus on improving endothelial function in women.

Black and white professional headshot of a man wearing a suit and smiling. 
Assistant Professor. University of Colorado Denver - Anschutz Medical Campus

Dr Zachary Clayton

Vascular physiology, oncology, environmental and clinical physiology

Dr Clayton is investigating the concurrent administration of mitoquinol alongside chemotherapy (e.g., doxorubicin), with a focus on mitigating treatment-induced oxidative stress and vascular dysfunction—an emerging application of mitochondrial-targeted antioxidants in oncology supportive care.

Medical College of Wisconsin

Dr Matthew Durand

Vascular health, stroke recovery
Leads clinical research evaluating mitoquinol to improve vascular function and functional outcomes in stroke survivors.


Trial: Vascular health post-stroke (NCT06930638)

A smiling woman with shoulder-length wavy hair, wearing a blazer over a lace top, outdoors with blurred trees in the background. 
Assistant Professor. University of Colorado Denver - Anschutz Medical Campus

Dr Vienna Brunt

Medicine-Renal Med Diseases/Hypertension

Dr Brunt is involved in research investigating mitoquinol in autosomal dominant polycystic kidney disease (ADPKD), where mitochondrial dysfunction and oxidative stress are believed to contribute to disease progression.

This work explores whether targeting mitochondrial ROS can provide a novel therapeutic approach for renal and vascular complications associated with ADPKD.

Black and white portrait of a smiling woman with dark hair, pearl earrings, and a pearl necklace, wearing a black top. 
Medical College of Wisconsin

Dr Jennifer McIntosh

Pregnancy complications, placental vascular function

Leads clinical research investigating mitoquinol as a therapeutic for preeclampsia, with a focus on restoring placental blood flow and improving maternal–fetal outcomes.

Her work is further supported by major external funding, including a grant from the Gates Foundation global challenges, recognising the global health potential of targeting mitochondrial dysfunction in pregnancy-related disease.

Contact Us